Disclosure of Annual Secretarial Compliance Certificate for the financial year ended March 31, 2026
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
JB Chemicals & Pharmaceuticals has filed its Annual Secretarial Compliance Report for FY 2025-26, audited by M/s N.L. Bhatia & Associates, Practising Company Secretaries. The audit covered compliance with SEBI regulations including LODR, SAST, PIT, Depositories, and Share Based Employee Benefits regulations. The company was found to be in full compliance with all applicable provisions — no deviations, violations, fines, or observations were reported. All 13 affirmation points including secretarial standards, policy updates, website disclosures, director disqualification checks, related party transactions, and insider trading norms were marked as compliant. No actions are pending against the company by SEBI or stock exchanges.
A clean compliance certificate with no red flags is positive for shareholders, indicating strong corporate governance and regulatory adherence. This filing is routine and has no direct impact on the stock price.